- Report
- May 2024
- 82 Pages
United States
From €2663EUR$2,975USD£2,268GBP
€3133EUR$3,500USD£2,669GBP
- Report
- November 2023
- 178 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4252EUR$4,750USD£3,622GBP
- Report
- February 2024
- 115 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- April 2023
- 100 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- April 2023
- 112 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- February 2024
- 230 Pages
Global
From €3984EUR$4,450USD£3,393GBP
- Report
- February 2024
- 80 Pages
North America
From €4252EUR$4,750USD£3,622GBP
- Report
- October 2023
- 170 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- February 2024
- 120 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- May 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,164GBP
- Report
- October 2023
- 82 Pages
North America
From €3088EUR$3,450USD£2,631GBP
- Report
- October 2023
- 95 Pages
Europe
From €3088EUR$3,450USD£2,631GBP
- Report
- October 2023
- 91 Pages
Asia Pacific
From €3088EUR$3,450USD£2,631GBP
- Report
- December 2022
- 189 Pages
Africa, Middle East
From €3088EUR$3,450USD£2,631GBP
- Report
- December 2022
- 202 Pages
Europe
From €3088EUR$3,450USD£2,631GBP
- Report
- December 2022
- 204 Pages
Asia Pacific
From €3088EUR$3,450USD£2,631GBP
- Report
- August 2022
- 330 Pages
Global
From €3984EUR$4,450USD£3,393GBP
- Report
- January 2024
- 83 Pages
Africa, Middle East
From €3088EUR$3,450USD£2,631GBP
- Report
- January 2024
- 79 Pages
From €3088EUR$3,450USD£2,631GBP

Alzheimer's Disease is a neurological disorder that affects memory, thinking, and behavior. It is the most common form of dementia, a group of disorders that cause a decline in cognitive function. Symptoms of Alzheimer's Disease include memory loss, difficulty with problem-solving, and changes in behavior. As the disease progresses, individuals may experience difficulty with language, disorientation, and difficulty with daily activities.
The Alzheimer's Disease market is a subset of the larger Neurology market. It is a rapidly growing market, driven by an aging population and increased awareness of the disease. Companies in the market are focused on developing treatments and therapies to improve the quality of life for those affected by the disease.
Companies in the Alzheimer's Disease market include Biogen, Eli Lilly, Novartis, and Roche. Other companies in the market include AbbVie, AstraZeneca, Merck, and Pfizer. Show Less Read more